A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ROXADUSTAT IN THE TREATMENT OF ANEMIA IN DIALYSISPATIENTS

Not Applicable

• Conditions: -D63-N18-Y841 Kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure; Kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure; D63; N18; Y841

• Registration Number: PER-067-14
• Lead Sponsor: ASTRAZENECA - PERU,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-02-25
• Study Completion: 2018-09-20
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

Ver Protocolo, Seccion 3.1

Exclusion Criteria

Ver Protocolo, Seccion 3.2

Study & Design

• Study Type: Interventional
• Study Design: Not specified